ÂÜÀòÂÒÂ×

Scott Yoder is a seasoned professional in program management with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Senior Director of CMC Program Management at Zentalis Pharmaceuticals, Scott previously held similar leadership roles at Turning Point Therapeutics and Novartis Gene Therapies, where oversight included CMC activities for clinical compounds and lifecycle management for gene therapy programs. Academic contributions include serving as an Adjunct Professor at the University of Wisconsin-Madison, teaching project management to graduate students. Scott's career encompasses numerous leadership positions focused on CMC program management, strategic initiatives, and global expansion, with a strong background in project execution and team leadership, supported by a Master's in Biotechnology and a Bachelor's in Biology and German from respected institutions.